SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001477932-18-003263
Filing Date
2018-06-29
Accepted
2018-06-29 13:50:18
Documents
63
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K nbio_10k.htm 10-K 485317
2 CERTIFICATION nbio_ex311.htm EX-31.1 7974
3 CERTIFICATION nbio_ex312.htm EX-31.2 8135
4 CERTIFICATION nbio_ex321.htm EX-32.1 3343
5 CERTIFICATION nbio_ex322.htm EX-32.2 3306
  Complete submission text file 0001477932-18-003263.txt   3110963

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT nbio-20180331.xml EX-101.INS 539073
7 XBRL TAXONOMY EXTENSION SCHEMA nbio-20180331.xsd EX-101.SCH 54570
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nbio-20180331_cal.xml EX-101.CAL 33634
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nbio-20180331_def.xml EX-101.DEF 157972
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE nbio-20180331_lab.xml EX-101.LAB 244646
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nbio-20180331_pre.xml EX-101.PRE 227548
Mailing Address 601 21ST STREET SUITE 300 VERO BEACH FL 32960
Business Address 601 21ST STREET SUITE 300 VERO BEACH FL 32960 612-961-5656
Nascent Biotech Inc. (Filer) CIK: 0001622057 (see all company filings)

IRS No.: 450612715 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-K | Act: 34 | File No.: 000-55299 | Film No.: 18928630
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1